UCSF 41st Annual Advances in Heart Disease 2024
Advanced Cardiovascular Medicine, Heart Failure & Contemporary Cardiology CME Program
Introduction
The UCSF 41st Annual Advances in Heart Disease 2024 is a comprehensive cardiovascular medicine conference presented by University of California San Francisco, designed to provide clinicians with the latest evidence-based advances in cardiology, preventive cardiovascular medicine, heart failure, electrophysiology, pulmonary hypertension, and critical care cardiology.
For more than four decades, the UCSF Advances in Heart Disease conference has served as a premier educational forum for cardiovascular specialists and healthcare professionals seeking clinically relevant updates that directly impact patient management. The 2024 program highlights major developments reported over the previous one to two years across a broad spectrum of cardiovascular diseases and therapies.
The course emphasizes practical application of modern cardiovascular evidence in areas such as:
- Heart failure management
- Weight loss drugs and cardiovascular health
- Arrhythmia management
- Critical care cardiology
- Mechanical circulatory support
- Coronary artery disease
- Pulmonary hypertension
- Anticoagulation therapy
- Peripheral artery disease
- STEMI and NSTEMI care
- Cardiovascular risk stratification
- Contemporary electrophysiology
- Cardiometabolic medicine
The conference combines expert faculty lectures, contemporary guideline review, clinical updates, and practical management strategies delivered by internationally recognized cardiovascular specialists and academic leaders.
You will find this course at medicalamboss.com
Course Overview
📚 Program: UCSF 41st Annual Advances in Heart Disease 2024
🏛️ Presented by: University of California San Francisco
📅 Course Year: 2024
🎥 Format: 5 Videos
💾 File Size: 7.91 GB
🎯 Educational Focus
- Coronary heart disease
- Heart failure
- Arrhythmias
- Critical care cardiology
- Pulmonary hypertension
- Mechanical circulatory support
- Anticoagulation
- Peripheral artery disease
- Cardiometabolic medicine
- Interventional cardiology
- Cardiovascular prevention
👨⚕️ Target Audience
- Cardiovascular specialists
- Practicing cardiologists
- Internists
- Family physicians
- Cardiovascular physician assistants
- Critical care physician assistants
- Cardiovascular nurses
- Critical care nurses
Educational Focus
This advanced cardiovascular medicine conference delivers clinically relevant education in:
- Evidence-based cardiology
- Heart failure management
- Electrophysiology
- Interventional cardiology
- Pulmonary vascular disease
- Cardiovascular prevention
- Cardiometabolic disease
- Critical care cardiology
The curriculum emphasizes recent clinical trial data and evolving guideline-based patient management.
Coronary Artery Disease & Acute Coronary Syndromes
A major component of the course focuses on modern ischemic heart disease management.
Topics Include
- Coronary heart disease
- STEMI management
- NSTEMI treatment
- Percutaneous coronary intervention
- Antiplatelet therapy
- Cardiovascular risk reduction
Participants review contemporary evidence-based approaches for acute and chronic coronary syndromes.
Heart Failure & Cardiometabolic Disease
Dedicated sessions provide advanced education in heart failure and metabolic cardiovascular health.
Covered Areas
- Systolic heart failure
- Diastolic heart failure
- HFpEF
- HFrEF
- Weight loss medications
- Diabetes and cardiovascular disease
- Cardiometabolic therapies
The curriculum emphasizes the growing role of obesity and metabolic interventions in cardiovascular outcomes.
Arrhythmias & Electrophysiology
Specialized lectures review contemporary arrhythmia management strategies.
Educational Topics
- Atrial fibrillation
- Atrial flutter
- Ventricular tachycardia
- Catheter ablation
- Electrophysiology advances
- Anticoagulation strategies
Participants strengthen understanding of modern rhythm management and procedural electrophysiology.
Critical Care Cardiology & Mechanical Circulatory Support
The course strongly emphasizes advanced cardiovascular critical care.
Included Areas
- Critical care cardiology
- Cardiogenic shock
- Mechanical circulatory support
- Hemodynamic management
- Acute cardiovascular emergencies
- ICU cardiovascular care
These sessions reinforce practical approaches to complex critically ill cardiac patients.
Pulmonary Hypertension & Vascular Disease
Advanced discussions focus on pulmonary vascular and peripheral arterial disorders.
Topics Covered
- Pulmonary hypertension
- Peripheral artery disease
- Thromboembolic disease
- Vascular risk stratification
- Cardiopulmonary interactions
- Advanced vascular therapies
The curriculum highlights evolving treatment paradigms and evidence-based vascular medicine.
Anticoagulation & Antiplatelet Therapy
A core educational theme centers on optimal cardiovascular pharmacotherapy.
Clinical Areas
- Anticoagulation management
- Antiplatelet therapy
- Thromboembolic disease
- Stroke prevention
- Bleeding risk assessment
- Contemporary cardiovascular pharmacology
Participants gain practical strategies for balancing ischemic and bleeding risks.
Diversity, COVID-19 & Cardiovascular Disease
The conference also addresses broader population health and emerging cardiovascular challenges.
Additional Themes
- Racial and ethnic cardiovascular disparities
- Personalized treatment approaches
- COVID-19 cardiovascular complications
- Population-based cardiovascular care
- Health equity in cardiology
These discussions reinforce comprehensive and individualized cardiovascular medicine.
Learning Experience
The course combines:
- Cardiovascular medicine
- Heart failure
- Coronary artery disease
- Arrhythmias
- Electrophysiology
- Pulmonary hypertension
- Critical care cardiology
- Interventional cardiology
- Cardiometabolic medicine
- Evidence-based clinical updates
The educational structure emphasizes recent research findings, practical implementation, and multidisciplinary cardiovascular care.
Who Should Enroll
This course is especially valuable for:
- Cardiologists
- Cardiovascular specialists
- Internists
- Family physicians
- Advanced practice providers
- Critical care clinicians
- Cardiovascular nurses
- Physician assistants
It is particularly useful for clinicians seeking broad evidence-based updates across modern cardiovascular medicine.
Why This Course Stands Out
Longstanding Prestigious Cardiovascular Program
Represents the 41st annual edition of a highly respected cardiology educational conference.
Broad Contemporary Cardiology Coverage
Addresses prevention, intervention, heart failure, electrophysiology, vascular disease, and critical care cardiology.
Focus on Recent Evidence
Highlights important clinical findings and guideline changes from the previous 1–2 years.
Strong Cardiometabolic Integration
Explores obesity medicine, diabetes, and weight loss therapies in cardiovascular care.
Expert Academic Faculty
Features distinguished visiting academicians and leading UCSF cardiovascular clinicians.
Clinical Value
The UCSF 41st Annual Advances in Heart Disease 2024 program delivers advanced cardiovascular medicine education through integrated coverage of:
- Coronary artery disease
- Heart failure
- Cardiometabolic disease
- Arrhythmias
- Electrophysiology
- Mechanical circulatory support
- Pulmonary hypertension
- Anticoagulation therapy
- Peripheral artery disease
- STEMI/NSTEMI management
- Cardiovascular prevention
- Critical care cardiology
The combination of evidence-based updates, multidisciplinary cardiovascular expertise, modern pharmacologic advances, and practical patient management strategies makes this conference highly valuable for contemporary cardiovascular clinical practice.
Topics:
- December 6 AM Session.mp4
- December 6 PM Session.mp4
- December 7 AM Session.mp4
- December 7 PM Session.mp4
- December 8 AM Session.mp4
* Detail:
| Friday, December 6, 2024 | ||
| 7:00 AM | Registration and Continental Breakfast | |
| 8:00 | Welcome and Symposium Overview | Peter Ganz, MD |
| Session: Frontiers in Interventional Cardiology | Chair: Lucas Zier, MD, MS | |
| 8:05 | Myocardial Infarction Without Obstructive Coronary Disease. What to Do? | Krishan Soni, MD, MBA |
| 8:45 | Complete Revascularization vs Culprit Only Revascularization: Understanding Each Strategy and When to Perform Each Approach | Ada Ip, MD |
| 9:25 | Orbita vs Orbita 2: Update on PCI for Stable CAD. | Lucas Zier, MD, MS |
| 10:05 | Coffee Break | |
| 10:20 | 2024 Updates on the Management of Valve Disease | Sammy Elmariah , MD, MPH |
| 11:00 | Surgical Management of Type A Aortic Dissection | Ramin Beygui, MD |
| 11:40 | Circulatory Support in Cardiogenic Shock: New Data and a New Era? | Connor O’Brien, MD |
| 12:20 PM | Lunch (on Your Own) | |
| Session: Managing Heart Failure | Chair: Jonathan Davis, MD, MPH | |
| 1:40 PM | New Drugs and Devices Coming Down Pipeline for Heart Failure | Liviu Klein, MD, MS |
| 2:15 | Genetic Testing for Heart Failure, Who Should Be Tested and What are We Looking For? | Julianne Wojciak, LGCG, MS |
| 2:50 | HFrEF Management | Jonathan Davis, MD, MPH |
| 3:25 | Coffee Break | |
| 3:40 | HFpEF Management | Jacqueline DesJardin, MD |
| 4:15 | Approach to and Management of Hypertrophic Cardiomyopathy | Theodore Abraham, MD |
| 4:50 | Approach to and Management of Cardiac Amyloid | Mandar Aras, MD, PhD |
| 5:25 PM | Adjourn | |
| Saturday, December 7, 2024 | ||
| 7:30 AM | Continental Breakfast | |
| 8:00 | Announcements | Peter Ganz, MD |
| Session: Advances and Controversies in Electrophysiology | Chair: Nora Goldschlager, MD | |
| 8:05 | Use and Misuse of Antiarrhythmic Drugs in 2025 | Gregory Marcus, MD, MAS |
| 8:45 | Extravascular Pacemakers and ICDs: Where Have All the Leads Gone? | Adam Oesterle, MD |
| 9:25 | Conduction System Pacing: Benefits, Outcomes and Risks | Joshua Moss, MD |
| 10:05 | Coffee Break | |
| 10:20 | Arrhythmogenic Cardiomyopathy | Melvin Scheinman, MD |
| 11:00 | What to Do with Incidentally Detected Atrial Fibrillation | Cara Pellegrini, MD |
| 11:40 | PVCs and non-Sustained VT. When to Worry. | Edward Gerstenfeld, MD, MS |
| 12:20 | Lunch (on your own) | |
| 1:40 PM | Achieving a Successful Ablation. Achieving a Successful Ablation. Patient Selection and Outcomes. | Thomas Dewland, MD |
| Session: Cardiovascular Risk Reduction and Prevention | Chair: Peter Ganz, MD | |
| 2:20 | Elliot Rapaport Keynote Lecture: How Failed Diabetes Drugs Led to a Revolution in Diabetes and Heart Failure Care. Convincing the FDA to Mandate Cardiovascular Outcome Trials for Diabetes Drug Approval | Steven Nissen, MD |
| 3:05 | New Prediction Tools from the AHA for Risk Assessment of Cardiovascular Disease | Peter Ganz, MD |
| 3:45 | Coffee Break | |
| 4:00 | Cardiovascular Disease in Type 1 Diabetes | Robert Eckel, MD |
| 4:40 | Pulmonary Hypertension, Contemporary Management and When to Refer | Marc Simon, MD, MS |
| 5:20 PM | Adjourn | |
| Sunday, December 8, 2024 | ||
| 7:30 AM | Continental Breakfast | |
| 8:00 | Announcements | Peter Ganz, MD |
| Session: Understanding and Managing Cardiovascular Risk | Chair: Peter Ganz, MD | |
| 8:05 | Sex diversity in heart-liver-metabolic axis risks and outcomes | Susan Cheng, MD, MMSc, MPH |
| 8:45 | PDE-5 inhibitors for Erectile Dysfunction: Do They Have Cardiovascular Protective Properties | Robert Kloner, MD, PhD |
| 9:25 | The Interplay of Cardiovascular and Kidney Disease | Julio Lamprea Montealegre, MD, PhD, MPH |
| 10:05 | Insights from Basic Science to Advance Understanding of Heart Failure | Arun Padmanabhan, MD, PhD |
| 10:25 | Weight Loss Drugs and Heart Health | Martha Gulati, MD, MS |
| 11:05 | Management of Stroke – Updates | Lauren Patrick, MD |
| 11:45 | Adjourn | |








